Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT
✍ Scribed by Stephan M. Wildi; Christoph Gubler; Thomas Hany; Henrik Petrowsky; Pierre A. Clavien; Wolfram Jochum; Tilman Gerlach; Michael Fried; Beat Mullhaupt
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 162 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0091-2751
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Combined fluorine 18‐fluorodeoxyglucose–positron emission tomography–CT imaging has been shown to be of good diagnostic value in the preoperative evaluation of patients with colorectal cancer and liver metastases. The adjunctive use of intraoperative sonography (IOUS) may have a limited impact on treatment selection in these patients.
Purpose
To compare the diagnostic performance of preoperative positron emission tomography (PET)‐CT alone and PET‐CT combined with IOUS in the evaluation of patients who are considered for curative resection of hepatic metastases from colorectal carcinoma.
Materials and Methods
Patients with colorectal cancer who underwent resection of hepatic metastases and preoperative PET‐CT (with or without contrast‐enhanced CT) and IOUS were identified. The performance of the imaging techniques was evaluated through review of the radiologic reports, correlation with surgical and histopathologic findings, and clinical follow‐up.
Results
Thirty‐one patients (mean age, 63.5 years [range, 53–82 years]) were analyzed. Fifteen patients had received preoperative chemotherapy. The mean interval between PET‐CT and IOUS was 22.6 days (range, 1–56 days). In 4 cases, neither PET‐CT nor IOUS correctly diagnosed the liver metastases. In all 31 patients, the sensitivity of PET‐CT alone and PET‐CT combined with IOUS was 63% (95% CI 44–80%) and 93% (95% CI 78–98%), respectively; the positive predictive value was 81% and 89%, respectively. In patients without preoperative chemotherapy (n = 16), the sensitivity of PET‐CT alone and PET‐CT combined with IOUS was 77% (95% CI 49–94%) and 100% (95% CI 79–100%), respectively. In 11 cases (35%), IOUS altered the surgical strategy.
Conclusion
In patients with colorectal carcinoma and potentially resectable liver metastases on preoperative PET‐CT, IOUS can provide additional information that may alter decision making with regard to surgical technique. © 2007 Wiley Periodicals, Inc. J Clin Ultrasound, 2008
📜 SIMILAR VOLUMES
Experimental studies in nude mice with human coloncarcinoma grafts demonstrated the therapeutic efficiency of F(abЈ) 2 fragments to carcinoembryonic antigen (CEA) labeled with a high dose of 131 Iodine. A phase I/II study was designed to determine the maximum tolerated dose of 131 I-labeled F(abЈ) 2
## Abstract ## Purpose To prospectively compare the capability for bone metastasis assessment of whole‐body diffusion‐weighted imaging (DWI), magnetic resonance imaging (MRI) without and with DWI, [^18^F] fluoro‐2‐D‐glucose positron emission tomography with computed tomography (FDG‐PET/CT) and bon
## Abstract ## Background The use of a single MRI and 18F‐fluoro deoxyglucose positron emission tomography‐CT (18F‐FDG PET‐CT) was evaluated, both in diagnostic procedure and radiotherapy planning, in patients with head and neck cancer. ## Methods Thirty‐five patients with nasopharyngeal and oro